Dermata Therapeutics (DRMA) Total Liabilities (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Total Liabilities of $1.1 million for Q1 2026, down 61.07% year-over-year from $2.7 million in Q1 2025, and down 35.83% quarter-over-quarter from $1.6 million in Q4 2025.
Dermata Therapeutics (DRMA) Total Liabilities (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 61.07% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 61.07% YoY), while the FY2025 annual figure was $1.6 million, down 16.85% from the prior year.
- Total Liabilities for Q1 2026 stood at $1.1 million, down from $1.6 million in the prior quarter.
- The five-year high for Total Liabilities was $2.7 million in Q1 2025, with the low at $682862.0 in Q2 2023.
- The 5-year median for Total Liabilities is $1.4 million (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2026: Total Liabilities surged 180.94% in 2024, then plunged 61.07% in 2026.
- Dermata Therapeutics' Total Liabilities stood at $922634.0 in 2022, then surged by 75.98% to $1.6 million in 2023, then grew by 21.51% to $2.0 million in 2024, then declined by 16.85% to $1.6 million in 2025, then plunged by 35.83% to $1.1 million in 2026.
- Business Quant data shows DRMA's Total Liabilities at $1.1 million in Q1 2026, $1.6 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 916,817.00 |
| Jun 30, 2023 | 682,862.00 |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 922,634.00 |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.64 Mn |